Premier Biotech was granted 510(k) clearance by the Food and Drug Administration for OralTox, a rapid oral fluid drug screen device that detects amphetamine, cocaine, marijuana, methamphetamine, opiates, and phencyclidine. OralTox provides results in less than 2 hours and has a demonstrated overall accuracy of greater than 99% agreement with liquid chromatography tandem-mass spectrometry (LC-MS/MS) results for each drug being tested. Premier Biotech’s lab also offers confirmations of presumptive positive results via LC-MS/MS. By using oral fluid as a testing matrix, this test is designed to offer numerous benefits over urine testing. The sample collection process is less invasive, can be fully observed without privacy concerns, and is resistant to adulteration, eliminating the need for specialized collection facilities. Another OralTox feature is a saturation indicator showing when sufficient sample has been collected. Additionally, the device enables drug testing clinics to put together customized panels and screen for multiple drugs simultaneously.